This review discusses the progress of India from being one of the largest producers of generics to
its coming of age and initiating novel drug development programs such as the Open Source Drug
Discovery for tuberculosis. A few groups have also begun to emerge which focus their research
on rational or structure based drug design. We discuss here some of the ongoing efforts in drug
discovery in India primarily in national research institutions and academia
